MX2016013451A - Heterociclilsulfonas arilo sustituidas. - Google Patents

Heterociclilsulfonas arilo sustituidas.

Info

Publication number
MX2016013451A
MX2016013451A MX2016013451A MX2016013451A MX2016013451A MX 2016013451 A MX2016013451 A MX 2016013451A MX 2016013451 A MX2016013451 A MX 2016013451A MX 2016013451 A MX2016013451 A MX 2016013451A MX 2016013451 A MX2016013451 A MX 2016013451A
Authority
MX
Mexico
Prior art keywords
substituted heterocyclyl
aryl substituted
sulfones
heterocyclyl sulfones
compounds
Prior art date
Application number
MX2016013451A
Other languages
English (en)
Inventor
Haurand Michael
Schunk Stefan
Reich Melanie
Damann Nils
Hamlyn Richard
Rogers Marc
Jakob Florian
MACKENZIE Kathy
Michael Koenigs René
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2016013451A publication Critical patent/MX2016013451A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

La invención se relaciona con heterociclilsulfonas arilo sustituidas como bloqueadores de canales de calcio activados por voltaje, para composiciones farmacéuticas que contengan estos compuestos y también para estos compuestos para utilizarse en el tratamiento y/o profilaxis de dolor y además enfermedades y/o trastornos.
MX2016013451A 2014-04-14 2015-04-14 Heterociclilsulfonas arilo sustituidas. MX2016013451A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14001345 2014-04-14
PCT/EP2015/000781 WO2015158426A1 (en) 2014-04-14 2015-04-14 Aryl substituted heterocyclyl sulfones

Publications (1)

Publication Number Publication Date
MX2016013451A true MX2016013451A (es) 2017-01-18

Family

ID=50486703

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013451A MX2016013451A (es) 2014-04-14 2015-04-14 Heterociclilsulfonas arilo sustituidas.

Country Status (12)

Country Link
US (1) US9896440B2 (es)
EP (2) EP3470406A1 (es)
JP (1) JP6653262B2 (es)
CN (1) CN106458955B (es)
AR (1) AR100071A1 (es)
AU (1) AU2015246386B2 (es)
BR (1) BR112016023926A2 (es)
CA (1) CA2945529A1 (es)
EA (1) EA032638B1 (es)
MX (1) MX2016013451A (es)
TW (1) TW201620886A (es)
WO (1) WO2015158426A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR100073A1 (es) 2014-04-14 2016-09-07 Gruenenthal Gmbh Sulfonas heterocíclicas sustituidas con heteroarilos
TW201726128A (zh) * 2015-10-08 2017-08-01 歌林達有限公司 經吡唑基取代之四氫哌喃基碸
TW201718557A (zh) 2015-10-08 2017-06-01 歌林達有限公司 經吡唑基取代之四氫吡喃基碸

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138680A1 (en) * 2000-03-29 2001-10-04 Pfizer Products Inc. Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
WO2007125398A2 (en) 2006-04-27 2007-11-08 Pfizer Japan Inc. : sulfonamide compounds as antagonists of the n-type calcium channel
GB0813142D0 (en) * 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
CA2771710A1 (en) * 2009-09-18 2011-03-24 Zalicus Pharmaceuticals Ltd. Aryl sulphone derivatives as calcium channel blockers
AR100073A1 (es) 2014-04-14 2016-09-07 Gruenenthal Gmbh Sulfonas heterocíclicas sustituidas con heteroarilos
TW201726128A (zh) 2015-10-08 2017-08-01 歌林達有限公司 經吡唑基取代之四氫哌喃基碸
TW201718557A (zh) 2015-10-08 2017-06-01 歌林達有限公司 經吡唑基取代之四氫吡喃基碸

Also Published As

Publication number Publication date
US20150291573A1 (en) 2015-10-15
BR112016023926A2 (pt) 2017-08-15
CN106458955B (zh) 2019-07-19
CN106458955A (zh) 2017-02-22
US9896440B2 (en) 2018-02-20
EA032638B1 (ru) 2019-06-28
JP6653262B2 (ja) 2020-02-26
JP2017511353A (ja) 2017-04-20
WO2015158426A1 (en) 2015-10-22
EA201692051A1 (ru) 2017-08-31
EP3470406A1 (en) 2019-04-17
EP3131884A1 (en) 2017-02-22
TW201620886A (zh) 2016-06-16
AU2015246386B2 (en) 2018-12-06
AR100071A1 (es) 2016-09-07
AU2015246386A1 (en) 2016-12-01
CA2945529A1 (en) 2015-10-22

Similar Documents

Publication Publication Date Title
MX2016013447A (es) Heterociclilsulfonas heteroarilo sustituidas.
MX2021009673A (es) Moduladores de ror-gamma.
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
PH12016501966B1 (en) Compounds and compositions as toll-like receptor 7 agonists
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MX2017005834A (es) Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
EA201691582A1 (ru) Новые фармацевтические препараты
MX2018004220A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
PT3377637T (pt) Composições para uso em métodos para o tratamento de ferimentos, transtornos e doenças da pele
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
IL270752B (en) Pyrrolopyridine-aniline compounds for the treatment of skin disorders
MX2016015896A (es) Composiciones que contienen azufre polimerico y usos de estas.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2018002446A (es) Compuestos heterociclicos fusionados como moduladores s1p.
MX2018004217A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
PH12016501393B1 (en) Substituted bicyclic heteroaryl compounds as rxr agonists
SG10201908881PA (en) Fused bicyclic compounds for the treatment of disease
GB201612043D0 (en) Composition for treatment of disorders
MX2016007955A (es) Pirrol carboxamidas iii fluorometil-sustituidas.
MX2016013451A (es) Heterociclilsulfonas arilo sustituidas.
PH12017501694A1 (en) Compositions for the treatment of fibrosis and fibrosis-related diseases
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
MX2016007951A (es) Pirrol carboxamidas iv fluorometil-sustituidas.
MX2016007956A (es) Pirrol carboxamidas fluorometil-sustituidas como bloqueadores del canal de calcio de cav2.2.